Key Takeaways
- • FYihealth Group, Canada's leading doctor-led eyecare platform and parent company of FYidoctors, Visique, BonLook, and Solis Optics, secured a strategic investment from KKR (NYSE: KKR), a global private equity and investment firm.
- • The investment by KKR-managed funds represents a significant capital infusion to support FYihealth's expansion strategy across its diversified eyecare portfolio, which operates across multiple brands and service verticals.
- • FYihealth demonstrated strong momentum heading into the partnership, having expanded to 370 clinic locations nationwide through 22 clinic mergers completed in 2025, positioning the company as Canada's largest diversified healthcare eyecare organization.
- • The partnership combines KKR's institutional capital and operational expertise with FYihealth's doctor-led business model, which emphasizes professional management and patient-focused care across retail optical, clinical eyecare, and branded eyewear segments.
Summary
FYihealth Group announced a strategic investment from funds managed by KKR, the New York Stock Exchange-listed global investment firm. Based in Calgary, Alberta, FYihealth serves as the parent platform for multiple eyecare brands including FYidoctors (Canada's leading diversified healthcare eye care provider), Visique, BonLook, and Solis Optics. The investment represents KKR's entry into the Canadian eyecare market through a partnership with a consolidating healthcare platform.
The timing of the investment reflects FYihealth's accelerated growth trajectory. In 2025, the company completed 22 clinic mergers and expanded its footprint to 370 locations nationwide, establishing itself as Canada's largest diversified eyecare organization. This record-breaking growth positioned FYihealth as an attractive platform for institutional capital seeking exposure to the consolidating eyecare sector, which combines clinical optometry services, optical retail, and branded eyewear distribution under a unified doctor-led management structure.
FYihealth's model emphasizes doctor-led ownership and professional management, differentiating it from purely retail-focused competitors. The company operates through multiple consumer-facing brands while maintaining clinical expertise at its core. KKR's investment provides growth capital to accelerate further clinic acquisitions, operational scaling, and potential geographic expansion, while leveraging KKR's global experience in healthcare consolidation and consumer-focused businesses. The partnership underscores institutional investor appetite for healthcare consolidation platforms in underserved markets with fragmented competitive landscapes.
The timing of the investment reflects FYihealth's accelerated growth trajectory. In 2025, the company completed 22 clinic mergers and expanded its footprint to 370 locations nationwide, establishing itself as Canada's largest diversified eyecare organization. This record-breaking growth positioned FYihealth as an attractive platform for institutional capital seeking exposure to the consolidating eyecare sector, which combines clinical optometry services, optical retail, and branded eyewear distribution under a unified doctor-led management structure.
FYihealth's model emphasizes doctor-led ownership and professional management, differentiating it from purely retail-focused competitors. The company operates through multiple consumer-facing brands while maintaining clinical expertise at its core. KKR's investment provides growth capital to accelerate further clinic acquisitions, operational scaling, and potential geographic expansion, while leveraging KKR's global experience in healthcare consolidation and consumer-focused businesses. The partnership underscores institutional investor appetite for healthcare consolidation platforms in underserved markets with fragmented competitive landscapes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.